.
. >>>
. >>> I
. >>> I WAS DIAGNOSED WITH STAGE
4PANCREATIC CANCER.
4PANCREATIC CANCER. I WILL FIGHT THIS.
I WILL KEEP WORKING AND WITH
THE LOVE AND SUPPORT OF
MY FAMILY AND FRIENDS, AND WITH
THE HELP 4@OF YOUR
PRAYERS ALSO, I PLAN TO BEAT
THE LOW SURVIVAL RATE
FOR THIS DISEASE.
>> I WILL TRY TO BE MORE REAL.
THE CANCER IS A KNOWN KILLER.
IT KILLED MY MOM WHO WAS 78.
IT KILLED CHRIS HOUSTON, A GOOD
FRIEND.
FRIEND.
FRIEND. THERE ARE SURVIVORS THOUGH LIKE
RUTH BADER GINSBERG
BUT IT'S A REALLY SHORT LIST.
JOINING ME TO BRING CONTEXT A
MEDICAL DOCTOR WITH
MEDSTAR.
MEDSTAR.
MEDSTAR. THANK YOU FOR JOINING US.
WHY IS THIS CANCER -- AFTER ALL
OF THIS TIME, ALL
THESE YEARS STILL SO DEADLY
>> ONE REASON IS WE DON'4@T HA
A GOOD SCREENING
TEST LIKE WE DO FOR OTHER
CANCERS.
CANCERS.
CANCERS. IT'S OFTEN FOUND TOO LATE.
IN 2019 THE ONLY WAY WE KNOW TO
CURE IT I4@S TO REMOVE
IT ALL IN ONE PIECE AND NOT
LEAVE A TRACE BEHIND.
UNFORT4@UNATELY VERY FEW PATIEN
HAVE THE OPPORTUNITY
TO UNDERGO THAT SURGERY BECAUSE
THE CANCER HAS
SPREAD BY THE TIME THEY ARE
DIAGNOSED.
DIAGNOSED. >> ARE THERE LIKELY
CANDIDATES.
CANDIDATES. >>> PEOPLE OR A GROUP OF
PEOPLE, WH4@ATEVER THAT --
PERHAPS WE CAN START SOME EARLY
SCREENINGS.
SCREENINGS. >> THERE ARE GROUPS WE THINK
THAT ARE AT HIGH RISK
FOR IT.
FOR IT.
FOR IT. ONE OF THE RISK IS PEOPLE WHO
HAVE CHRONIC
HAVE CHRONIC PANCREATITIS.
PANCREATITIS. THE BIGGEST RISK IS IN PATIENTS
WHEN HAVE A FAMILY4@
HISTORY OF IT OR SIMILAR TYPE
CANCERS LIKE BREAST O
OR OVARIAN CANCER.
CERTAIN SYNDROMES INCREASE THE
RISKS.
RISKS.
RISKS. THOSE PATIENTS HAVE 4@SCREENING
RECOMMENDATIONS WHERE
RECOMMENDATIONS WHERE THEY SHOULD UNDERGO SCREENINGS
EARLY ON IN LIFE.
>> WHY DO MOST OF THE CASES WE
HEAR ABOUT --
ALREADY ADVANCED, STAGE 4
>> OFTEN TIMES THERE AREN'T A
LOT OF SYMPTOMS
BEFORE THE CANCER SPREADS.
THERE ARE A FEW 4@WHO PRESENT
WITH PAINLESS JAUNDICE. MANY
PATIENTS PRESENT WITH SORT OF
VAGUE,
VAGUE,
VAGUE, NONSPECIFIC SYMPTOMS, STOMACH
PAIN.
PAIN.
PAIN. FEELING FULL AFTER A MEAL
QUICKER THAN 4@NORMAL.
SORT OF VAGUE, HEARTBURN TYPE
SYMPTOMS.
SYMPTOMS.
SYMPTOMS. SYMPTOMS ARE OFTEN COMPLETELY
SOMETHING ELSE.
SOMETHING ELSE. FOR THOSE REASONS OFTEN TIMES
PEOPLE PRESENT LATER
AND BY THAT POINT THE CANCER
HAS SPREAD.
HAS SPREAD. >> WHY 4@IS IT THAT -- THOSE
THAT DO SURVIVE, JUST
LUCKY
LUCKY
LUCKY >>
LUCKY >> THERE'S -- I THINK A COUPLE
GROUPS.
GROUPS.
GROUPS. >> WHAT'S THE NUMBER THERE
>> TAKING ALL KUMMERS WITH
CANCER, THE FIVE YEAR
SURRENDE4@R VIALAL RATE IS A 9%
OUT OF 100 PEOPLE 91 ARE DEAD
WITH IN 4@FIVE YEARS.
AS BAD AS THAT SOUNDS IT USED
TO BE TWO, 3%.
WE ARE MAKING SOME SMALL
IMPROVEMENTS BUT THERE'S A
LONG WAY TO GO.
FOR ALEX TREBEK, 4@THAT NUMBER
DROPS TO ABOUT 2.7%
MEAN THAT ALMOST ALL PATIENTS
ARE 4@DEAD WITH IN FIVE
YEARS.
YEARS.
YEARS. NOW, THE PEOPLE WHO ARE FOUND
VERY EARLY, OFTEN --
LIKE RUTH BADER GINSBERG.
IF YOU FIND IT VERY EARLY THOSE
PATIENTS ARE OFTEN 4@4@
THE ONES THAT ARE IN THAT 9%
WHO CAN GET THE SURGERY
AND NOW WHAT WE 4@RECOMMEND IS
FAIRLY INTENSIVE CHEMO
TO KILL WHAT WE THINK ARE CELL
THAT ARE PROBABLY
ALREADY THERE BY THE TIME WE
CAN SEE SOMETHING BIG
ENOUGH TO LIGHT UP ON THE CT 4@
SCAN.
SCAN.
SCAN. >>
SCAN. >> AND THE SURVIVOR.
WHY DON'T WE JUST SCREEN
EVERYBODY
EVERYBODY
EVERYBODY >> THAT'S A VERY GOOD
QUESTION.
QUESTION.
QUESTION. EVEN IF WE CAN SEE A 4@MASS ON
SCAN IT CAN STILL BE
HARD TO GET THE DIAGNOSIS.
THE MAIN WAY TO DO IT IS A 4@
ULTRASOUND LIKE -- THE
COLOMSCOPY BUT THEY GO THROUGH
THE MASS AND THE
PROBE ON THE 4@END AND THEY LOO
AROUND THROUGH THE
STOMACH WALL AND TRY TO FIND
THE MASS 4@AND STICK A
NEEDLE INTO IT.
I HAD MANY OF THESE 4@AND STILL
CAN'T GET A TISSUE
DIAGNO4@SIS.
DIAGNO4@SIS. WE CAN'T GET CELLS 4@UNDER A
MICROSCOPE.
MICROSCOPE. IF YOU START SCREENING LARGE
GROUPS OF THE
POPULATION THAT'S VERY INVASIVE
AND THAT'S THE BEST
TEST WE HAVE.
WHAT 4@IS IMPORTANT IS TO BETTE
SCREEN.
SCREEN.
SCREEN. THOSE HIGH RISK POPULA4@TIONS.
THOSE POPULATION 4@WAS THE STRO
FAMILY HISTORY.
FAMILY HISTORY. THOSE POPULATIONS WITH NEW 4@
ONSET DIABETES AFTER AGE
50.
50.
50. ME
50. ME THINK THERE'S A GOOD SUBSET
OF THAT POPULATION
THAT COULD DEVELOP IT AND THEN
BETTER SCREENINGS
BETTER SCREENINGS TESTS.
TESTS.
TESTS. THERE'S A LOT OF TEST THAT CAN
NARROW THAT DOWN TO A
GROUP THAT 4@SHOULD HAVE THAT
SCREENING.
SCREENING. >> HERE IS MY EXTRA QUESTION.
THE COST.
THE COST.
THE COST. IS THAT A PROBLEM
IS THAT WHY WE AREN'T DOING
MORE
MORE
MORE BECAUSE THE COST IS.
>> COST OF SCREENING IS ALWAYS
AN ISSUE REGARDLESS
OF THE SCREENING TEST.
FOR A SCREENING TEST TO 4@BE
EFFECTIVE IT HAS TO FIND
EARLY STAGE DISEASE.
THAT -- COULD BE CURED AND LEAD
TO L4@ONG TERM